These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 9741412)
21. Effect of L-carnitine on the zidovudine-induced destruction of human myotubes. Part I: L-carnitine prevents the myotoxicity of AZT in vitro. Semino-Mora MC; Leon-Monzon ME; Dalakas MC Lab Invest; 1994 Jul; 71(1):102-12. PubMed ID: 7518879 [TBL] [Abstract][Full Text] [Related]
22. HIV-1 therapy and fetal mitochondrial dysfunction. Poulton J; Lyall H; Taylor G; Williams GT Lancet; 1999 Dec; 354(9195):2081-2. PubMed ID: 10636397 [No Abstract] [Full Text] [Related]
23. Type B lactic acidosis in an AIDS patient treated with zidovudine. Aggarwal A; al-Talib K; Alabrash M Md Med J; 1996 Nov; 45(11):929-31. PubMed ID: 8942169 [TBL] [Abstract][Full Text] [Related]
27. Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3'-azido-3'-deoxythymidine. Gerschenson M; Erhart SW; Paik CY; St Claire MC; Nagashima K; Skopets B; Harbaugh SW; Harbaugh JW; Quan W; Poirier MC AIDS Res Hum Retroviruses; 2000 May; 16(7):635-44. PubMed ID: 10791874 [TBL] [Abstract][Full Text] [Related]
28. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Arnaudo E; Dalakas M; Shanske S; Moraes CT; DiMauro S; Schon EA Lancet; 1991 Mar; 337(8740):508-10. PubMed ID: 1671889 [TBL] [Abstract][Full Text] [Related]
32. Retroviruses and inflammatory myopathies in humans and primates. Dalakas MC Baillieres Clin Neurol; 1993 Nov; 2(3):659-91. PubMed ID: 8156147 [TBL] [Abstract][Full Text] [Related]
33. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity. Divi RL; Leonard SL; Kuo MM; Nagashima K; Thamire C; St Claire MC; Wade NA; Walker VE; Poirier MC Environ Mol Mutagen; 2007; 48(3-4):201-9. PubMed ID: 16538687 [TBL] [Abstract][Full Text] [Related]
34. Zidovudine causes early increases in mitochondrial ribonucleic acid abundance and induces ultrastructural changes in cultured mouse muscle cells. d'Amati G; Lewis W Lab Invest; 1994 Dec; 71(6):879-84. PubMed ID: 7528833 [TBL] [Abstract][Full Text] [Related]
35. Prognosis in AZT myopathy. Chalmers AC; Greco CM; Miller RG Neurology; 1991 Aug; 41(8):1181-4. PubMed ID: 1714057 [TBL] [Abstract][Full Text] [Related]
36. Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells. Benbrik E; Chariot P; Bonavaud S; Ammi-Saïd M; Frisdal E; Rey C; Gherardi R; Barlovatz-Meimon G J Neurol Sci; 1997 Jul; 149(1):19-25. PubMed ID: 9168161 [TBL] [Abstract][Full Text] [Related]
37. HIV or zidovudine myopathy? Dalakas M Neurology; 1994 Feb; 44(2):360-1; author reply 362-4. PubMed ID: 8309594 [No Abstract] [Full Text] [Related]
38. AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins. de la Asunción JG; del Olmo ML; Sastre J; Millán A; Pellín A; Pallardó FV; Viña J J Clin Invest; 1998 Jul; 102(1):4-9. PubMed ID: 9649550 [TBL] [Abstract][Full Text] [Related]
39. Evidences that zidovudine (AZT) could not be directly responsible for iron overload in AZT-treated patients: an in vitro study. D'Alessandro AM; Rinaldi AC; D'Andrea G; Brisdelli F; Di Ciccio L; Di Giulio A; Oratore A; Bozzi A Clin Chim Acta; 2000 Oct; 300(1-2):119-30. PubMed ID: 10958868 [TBL] [Abstract][Full Text] [Related]
40. A comparison of genetic mitochondrial disease and nucleoside analogue toxicity. Does fetal nucleoside toxicity underlie reports of mitochondrial disease in infants born to women treated for HIV infection? Haas RH Ann N Y Acad Sci; 2000 Nov; 918():247-61. PubMed ID: 11131711 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]